Jakafi (Ruxolitinib)

Save over 80% on brand name Jakafi (Jakavi or Jukavi in Europe). 

All English packaging except the 10mg strength.

According to the European Medicines Agency, brand name Jakavi originating from Europe is manufactured at the following site(s):

Novartis Farmacéutica S.A.
Gran Via de les Corts Catalanes, 764
08013 Barcelona
Spain

Novartis Pharma GmbH
Roonstrasse 25
90429 Nuremberg
Germany

 

Jakafi (Jakavi in UK) is used in the treatment of adults with an enlarged spleen or symptoms of myelofibrosis,  Jakafi is also used in place of hydroxyurea where the patient is resistant or intolerant.  Jakafi is prescribed by physicians with special treatment experience.